B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TRAP1

MOLECULAR TARGET

TNF receptor associated protein 1

UniProt: Q12931NCBI Gene: 101317 compounds

TRAP1 (TNF receptor associated protein 1) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TRAP1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1luminespib3.5835
2biib0213.0420
3pu h712.8917
4snx 21122.7715
5ganetespib2.7114
619-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin [Supplementary Concept]0.691
7triolimus [Supplementary Concept]0.691

About TRAP1 as a Drug Target

TRAP1 (TNF receptor associated protein 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented TRAP1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TRAP1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.